TMCnet News

Research and Markets: Coagulation Self-Testing Market to 2020
[June 29, 2015]

Research and Markets: Coagulation Self-Testing Market to 2020


Research and Markets (http://www.researchandmarkets.com/research/fhdmp3/coagulation) has announced the addition of the "Coagulation Self-testing to 2020" report to their offering.

The size and future potential of the coagulation self-testing market has been evolving over the past 24 months as two competing forces work to inject uncertainty into future demand. Demographic and incidence data indicate a definite upward trend in the clinical and managed care demand for anticoagulation therapeutics. But the commercialization of novel oral anticoagulants (NOACs) - a new class of drugs that does not require routine coagulation monitoring - will work to reduce demand for coagulation self-testing.

The result will be a muddled global market where demand among countries and regions will vary based on individual market factors. To minimize risk and fully engage addressable markets, participants must commit to a comprehensive understanding of the key markets in which they currently, or plan to, compete.

What You Will Learn

- What are the marketed patient self-testing devices for measuring and monitoring anticoagulation drug therapy?

- What is the status and prospects of coagulation self-test devices currently in development?

- What is the market potential and commercialization risks and opporunities for coagulation self-test devices?



- What are the key patient self-test device design issues and evolving market factors for coagulation self-testing?

- What is the impact of coagulation self-test technology and devices on coagulation management markets?


- What is the role and impact of third-party PT/INR self-test services on device demand and patient acceptance?

- Who are the market participants in the coagulation self-test segment, and what are their technology and market strategies?

- Who are the market leaders; what is the size of the market today, and what will it be in 2020?

- What is the impact of novel oral anticoagulants on the future commercial growth of coagulation self-test devices?

Key Topics Covered:

1. Executive Summary

2. Anticoagulation Therapy Market Dynamics

- Anticoagulation Healthcare Economics

- Oral Anticoagulation Therapy

- Monitoring Prothrombin Time

- Competing Coagulation Tests

- Key Factors in Patient Compliance

- Market Drivers

- Industry Alignment and Competitive Landscape

3. Coagulation Self-Testing Device Design Factors

- Standardization of PT/INR Testing

- Accuracy and Precision

- Sampling Method

- Endpoint Detection

- Patient/User Interface

- Wireless Technology

4. Commercialization Factors

- Managed Care and Reimbursement

- Third-party Patient Training & Support

- Proprietary Technology

5. Market Factors

- Indications and Market Segments

- Novel Oral Anticoagulants

- Patient Demographics

- Regulations and Standards

- Patient/Consumer Sentiment

6. Patient Self-Testing Product Assessments

- Commercial Products

- CoaguChek

- CoaguSense

- InRatio

- i-STAT

7. Development-Stage Devices

- iLine Microsystems

- Microvisk

- Universal Biosensors

- FlexLife Health

8. Market Analysis, Data and Forecasts

- North America

- Western Europe

- Eastern Europe

- Asia

- MENA

- South America

9. Company Profiles

For more information visit http://www.researchandmarkets.com/research/fhdmp3/coagulation


[ Back To TMCnet.com's Homepage ]